Strides Pharma Science Ltd

STAR Stock View

(NSE)

341.00

0.00
Proj. ROE (%)
3.30
Proj. P/E (x)
31.00
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
1.01
Proj. Revenue ( Cr.)
3,950.50

Stock View

STRONG BUY
Share on
The average score for Strides Pharma Science Ltd stands at 6 against 4, three months back.

Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on development and manufacture of IP-led niche and pharmaceutical products. It operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as, liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
331.43
100 DMA ()
331.52
200 DMA ()
385.47
52 Weeks Range
263.35
725.80
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity